September

September

Should Cancer Be ‘Controlled’ Instead of ‘Eliminated’?

By Admin at 30 Sep 2016

Scientists are looking into therapies that slow the growth of cancer cells on a long-term basis, to the point that they no longer pose a significant health risk — in essence turning cancer into a manageable chronic condition. When this occurs, elimination of the cancer may no longer be necessary.

0 comments posted

NASA Research Furthers the Fight Against Cancer

By Administrator at 28 Sep 2016

What does NASA's Jet Propulsion Laboratory (JPL) have in common with the National Cancer Institute (NCI)? The need to mine through mind-boggling amounts of data. In NASA’s case, the data is astronomical and results from probes, satellites and other instruments that pull data from space. NCI, meanwhile, is attempting to sort through impressive amounts of biomedical data that could help in the fight against cancer.

0 comments posted

Brain Cancer Surpasses Leukemia as Deadliest Childhood Cancer

By Admin at 23 Sep 2016

While childhood cancer is often associated with leukemia, data from the U.S. Centers for Disease Control and Prevention (CDC) found that brain cancer is now the deadliest pediatric cancer.

0 comments posted

Halting Fat Synthesis May Stifle Cancer Growth

By Admin at 21 Sep 2016

Researchers from the Salk Institute in California hypothesized that halting fat synthesis in cancer cells may essentially stop their growth, and they recently figured out a way to test out their hypothesis — with exciting results.

0 comments posted

Natural Hormone Melatonin May Slow Breast Cancer Growth

By Admin at 14 Sep 2016

In a new study conducted by researchers at Michigan State University (MSU), melatonin’s apparent cancer-fighting powers were further revealed.

0 comments posted

    Categories

    Archive

    2018 2017 2016 2015
    99 cents of every dollar received directly funds cancer clinical trials

    57

    Current Gateway-funded clinical trials

    150+

    Clinical trials funded at leading institutions worldwide

    $16.56

    Funds one patient for one day at a Gateway-funded clinical trial

     
     

    Mission Partners